Evidence map›Paper›PMID 26908424›Full record

Trial reportEuropean journal of clinical nutrition2016

Steady-state vitamin K2 (menaquinone-7) plasma concentrations after intake of dairy products and soft gel capsules.

M H J Knapen, L A J L M Braam, K J Teunissen, C M Van't Hoofd, R M L Zwijsen, E G H M van den Heuvel, C Vermeer

Open access · bronzeAbstract readComparative StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in European journal of clinical nutrition, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

M H J KnapenR&D Group VitaK, Biopartner Center Maastricht, Maastricht University, Maastricht, The Netherlands.
L A J L M BraamR&D Group VitaK, Biopartner Center Maastricht, Maastricht University, Maastricht, The Netherlands.
K J TeunissenR&D Group VitaK, Biopartner Center Maastricht, Maastricht University, Maastricht, The Netherlands.
C M Van't HoofdR&D Group VitaK, Biopartner Center Maastricht, Maastricht University, Maastricht, The Netherlands.
R M L ZwijsenFrieslandCampina, Amersfoort, The Netherlands.
E G H M van den HeuvelFrieslandCampina, Amersfoort, The Netherlands.
C VermeerR&D Group VitaK, Biopartner Center Maastricht, Maastricht University, Maastricht, The Netherlands.
Maastricht University · NLFrieslandCampina (Netherlands) · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn a previous human intervention study, we observed an improved vitamin K status after 8 weeks of intake of a yogurt that was fortified with vitamin K2 (as menaquinone-7, MK-7) and enriched with vitamins C and D3, magnesium and polyunsaturated fatty acids. It was hypothesized that the added nutrients contributed to this improvement. Here we report on a study in which we compared the fasting plasma concentrations of MK-7 from (a) yogurt enriched with MK-7, vitamins D3 and C, magnesium, n-3 poly unsaturated fatty acids (n-3 PUFA) and fish oil (yogurt Kplus), (b) yogurt fortified with MK-7 only (yogurt K) and (c) soft gel capsules containing only MK-7. SUBJECTS/

methodsFor 42 days, healthy men and postmenopausal women between 45 and 65 years of age daily consumed either yogurt K, yogurt Kplus or capsules. Circulating MK-7, 25-hydroxy vitamin D (25(OH)D) and markers for vitamin K status (uncarboxylated osteocalcin (ucOC) and desphospho-uncarboxylated matrix Gla-protein (dp-ucMGP)) were assessed. Plasma MK-7 was also measured during the washout period of 2 weeks. MK-7 and dp-ucMGP were measured in citrated plasma, and 25(OH)D3 and ucOC were measured in the serum.

resultsThe increase in plasma MK-7 with the yogurt Kplus product was more pronounced than the increase in MK-7 with the capsules. Circulating dp-ucMGP and ucOC were significantly lowered after consumption of the yogurt products and the MK-7 capsules, reflecting vitamin K status improvement. No significant differences in fasting plasma concentrations of various biomarkers between the yogurts were found.

conclusionsDairy matrix and nutrient composition may affect MK-7 delivery and improvement of vitamin K status. Yogurt fortified with MK-7 is a suitable matrix to improve the nutritional status of the fat-soluble vitamins.

Indexed as

DietDietary SupplementsFood, FortifiedYogurtAscorbic AcidBiological AvailabilityCalcium-Binding ProteinsCapsulesCholecalciferolDairy ProductsDietary FatsExtracellular Matrix ProteinsFastingFatty Acids, Omega-3FemaleHumansAscorbic AcidCalcium-Binding ProteinsCapsulesCholecalciferolDietary FatsExtracellular Matrix ProteinsFatty Acids, Omega-3MagnesiumMatrix Gla Proteinmenaquinone 7MicronutrientsOsteocalcinVitamin K 2

Identifiers

PMID26908424
OpenAlexW2336384354

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.